227 related articles for article (PubMed ID: 22085389)
1. Liraglutide: a review of its use in the management of type 2 diabetes mellitus.
Perry CM
Drugs; 2011 Dec; 71(17):2347-73. PubMed ID: 22085389
[TBL] [Abstract][Full Text] [Related]
2. Liraglutide: a review of its use in type 2 diabetes mellitus.
Croom KF; McCormack PL
Drugs; 2009 Oct; 69(14):1985-2004. PubMed ID: 19747013
[TBL] [Abstract][Full Text] [Related]
3. Liraglutide in type 2 diabetes mellitus.
Baruah MP; Chaudhury T; Sethi BK; Dharmalingam M
J Indian Med Assoc; 2012 May; 110(5):335-8. PubMed ID: 23360033
[TBL] [Abstract][Full Text] [Related]
4. A review of efficacy and safety data regarding the use of liraglutide, a once-daily human glucagon-like peptide 1 analogue, in the treatment of type 2 diabetes mellitus.
Montanya E; Sesti G
Clin Ther; 2009 Nov; 31(11):2472-88. PubMed ID: 20109994
[TBL] [Abstract][Full Text] [Related]
5. The safety and efficacy of liraglutide with or without oral antidiabetic drug therapy in type 2 diabetes: an overview of the LEAD 1-5 studies.
Blonde L; Russell-Jones D
Diabetes Obes Metab; 2009 Dec; 11 Suppl 3():26-34. PubMed ID: 19878259
[TBL] [Abstract][Full Text] [Related]
6. Clinical pearls for initiating and utilizing liraglutide in patients with type 2 diabetes.
Gross B
J Pharm Pract; 2013 Apr; 26(2):144-50. PubMed ID: 23204146
[TBL] [Abstract][Full Text] [Related]
7. Liraglutide: a once-daily incretin mimetic for the treatment of type 2 diabetes mellitus.
Neumiller JJ; Campbell RK
Ann Pharmacother; 2009 Sep; 43(9):1433-44. PubMed ID: 19638470
[TBL] [Abstract][Full Text] [Related]
8. Liraglutide: once-daily GLP-1 agonist for the treatment of type 2 diabetes.
Ryan GJ; Hardy Y
J Clin Pharm Ther; 2011 Jun; 36(3):260-74. PubMed ID: 21545609
[TBL] [Abstract][Full Text] [Related]
9. Liraglutide (Victoza) for type 2 diabetes.
Med Lett Drugs Ther; 2010 Apr; 52(1335):25-7. PubMed ID: 20360660
[TBL] [Abstract][Full Text] [Related]
10. Liraglutide: a review of its use in adult patients with type 2 diabetes mellitus.
Scott LJ
Drugs; 2014 Dec; 74(18):2161-74. PubMed ID: 25367717
[TBL] [Abstract][Full Text] [Related]
11. Liraglutide - overview of the preclinical and clinical data and its role in the treatment of type 2 diabetes.
Davies MJ; Kela R; Khunti K
Diabetes Obes Metab; 2011 Mar; 13(3):207-20. PubMed ID: 21205109
[TBL] [Abstract][Full Text] [Related]
12. Liraglutide: from clinical trials to clinical practice.
Gough SC
Diabetes Obes Metab; 2012 Apr; 14 Suppl 2():33-40. PubMed ID: 22405267
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the efficacy and tolerability profile of liraglutide, a once-daily human GLP-1 analog, in patients with type 2 diabetes ≥65 and <65 years of age: a pooled analysis from phase III studies.
Bode BW; Brett J; Falahati A; Pratley RE
Am J Geriatr Pharmacother; 2011 Dec; 9(6):423-33. PubMed ID: 22055210
[TBL] [Abstract][Full Text] [Related]
14. Liraglutide in clinical practice: dosing, safety and efficacy.
Peterson GE; Pollom RD
Int J Clin Pract Suppl; 2010 Oct; (167):35-43. PubMed ID: 20949699
[TBL] [Abstract][Full Text] [Related]
15. Potential of liraglutide in the treatment of patients with type 2 diabetes.
Deacon CF
Vasc Health Risk Manag; 2009; 5(1):199-211. PubMed ID: 19436648
[TBL] [Abstract][Full Text] [Related]
16. Albiglutide: a review of its use in patients with type 2 diabetes mellitus.
Blair HA; Keating GM
Drugs; 2015 Apr; 75(6):651-63. PubMed ID: 25777969
[TBL] [Abstract][Full Text] [Related]
17. Liraglutide: a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes mellitus.
Joffe D
Am J Health Syst Pharm; 2010 Aug; 67(16):1326-36. PubMed ID: 20689121
[TBL] [Abstract][Full Text] [Related]
18. Liraglutide in oral antidiabetic drug combination therapy.
Garber AJ
Diabetes Obes Metab; 2012 Apr; 14 Suppl 2():13-9. PubMed ID: 22405265
[TBL] [Abstract][Full Text] [Related]
19. An overview of the pharmacokinetics, efficacy and safety of liraglutide.
Bode B
Diabetes Res Clin Pract; 2012 Jul; 97(1):27-42. PubMed ID: 22245694
[TBL] [Abstract][Full Text] [Related]
20. Glycaemic control with liraglutide: the phase 3 trial programme.
Raskin P; Mora PF
Int J Clin Pract Suppl; 2010 Oct; (167):21-7. PubMed ID: 20887301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
